Aspire Biopharma Holdings, Inc. to Launch its BUZZ BOMB Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World
Aspire Biopharma Holdings (NASDAQ:ASBP) announced the launch of its new pre-workout supplement BUZZ BOMBā� at two major fitness conventions - FitCon in Salt Lake City (August 1-2) and FitExpo in Anaheim (August 2-3, 2025).
The product features 50mg of caffeine delivered through sublingual nano technology, offering nearly instant energy through easy-to-use packets. As a Gold Sponsor at FitCon (20,000 attendees) and sponsor at FitExpo (33,000 attendees), BUZZ BOMBā� will receive prominent placement, extensive marketing exposure, and product sampling opportunities to all attendees.
The company aims to disrupt the multi-billion-dollar pre-workout market with its innovative delivery system that provides immediate effects compared to traditional pre-workout supplements that require 20-30 minutes to activate.
Aspire Biopharma Holdings (NASDAQ:ASBP) ha annunciato il lancio del suo nuovo integratore pre-allenamento BUZZ BOMBā� in due importanti convention fitness: FitCon a Salt Lake City (1-2 agosto) e FitExpo a Anaheim (2-3 agosto 2025).
Il prodotto contiene 50mg di caffeina somministrata tramite tecnologia sublinguale nano, offrendo energia quasi istantanea attraverso pratiche bustine. Come sponsor Gold a FitCon (20.000 partecipanti) e sponsor a FitExpo (33.000 partecipanti), BUZZ BOMBā� avrĆ una posizione di rilievo, ampia visibilitĆ pubblicitaria e opportunitĆ di campionamento per tutti i presenti.
Lāazienda punta a rivoluzionare il mercato multi-miliardario dei pre-allenamento con un sistema di somministrazione innovativo che garantisce effetti immediati, a differenza dei tradizionali integratori che richiedono 20-30 minuti per attivarsi.
Aspire Biopharma Holdings (NASDAQ:ASBP) anunció el lanzamiento de su nuevo suplemento pre-entrenamiento BUZZ BOMBā� en dos importantes convenciones de fitness: FitCon en Salt Lake City (1-2 de agosto) y FitExpo en Anaheim (2-3 de agosto de 2025).
El producto contiene 50 mg de cafeĆna administrados mediante tecnologĆa nano sublingual, ofreciendo energĆa casi instantĆ”nea a travĆ©s de prĆ”cticos sobres. Como patrocinador Gold en FitCon (20,000 asistentes) y patrocinador en FitExpo (33,000 asistentes), BUZZ BOMBā� tendrĆ” una ubicación destacada, amplia exposición de marketing y oportunidades para muestrear el producto a todos los asistentes.
La compaƱĆa busca revolucionar el mercado multimillonario de suplementos pre-entrenamiento con un sistema de entrega innovador que proporciona efectos inmediatos en comparación con los suplementos tradicionales que requieren 20-30 minutos para activarse.
Aspire Biopharma Holdings (NASDAQ:ASBP)ė� ģė”ģ� ģ“ė ģ � 볓충ģ � BUZZ BOMBā�ģ� ė� ź°ģ 주ģ ķ¼ķøėģ¤ ģ»Øė²¤ģ ģø ģķøė ģ“ķ¬ģķ°ģ FitCon(8ģ� 1-2ģ�)ź³� ģ ėķģģ� FitExpo(2025ė � 8ģ� 2-3ģ�)ģģ ģ¶ģķė¤ź³� ė°ķķģµėė¤.
ģ� ģ ķģ 50mgģ� 칓ķģ�ģ� ģ¤ķ ėė ø źø°ģ ė”� ģ ź³µķģ¬ ź°ķøķ� ķ� ķķė”� ź±°ģ ģ¦ź°ģ ģø ģėģ§ė„� ģ ź³µķ©ėė�. FitCon(ģ°øź°ģ� 20,000ėŖ�)ģģ ź³Øė ģ¤ķ°ģė”, FitExpo(ģ°øź°ģ� 33,000ėŖ�)ģģ ģ¤ķ°ģė”ģ� BUZZ BOMBā¢ė ėģ ėė ģģ¹, ź“ė²ģķ ė§ģ¼ķ� ė øģ¶ ė°� ėŖØė ģ°øź°ģģź²� ģ ķ ģķė§� źø°ķė„� ģ»ź² ė©ėė�.
ķģ¬ė� 기씓 ģ“ė ģ � ė³“ģ¶©ģ ź° ķģ±ķėźø°ź¹ģ§ 20-30ė¶ģ“ 걸리ė� ź²ź³¼ ė¬ė¦¬ ģ¦ź°ģ ģø ķØź³¼ė„� ģ ź³µķė ķģ ģ ģø ģ ė¬ ģģ¤ķ ģ¼ė”� ģģģ� ė¬ė¬ ź·ėŖØģ� ģ“ė ģ � 볓충ģ � ģģ„ģ� ķģ ķė ź²ģ ėŖ©ķė”� ķź³ ģģµėė¤.
Aspire Biopharma Holdings (NASDAQ:ASBP) a annoncĆ© le lancement de son nouveau supplĆ©ment prĆ©-entraĆ®nement BUZZ BOMBā� lors de deux grandes conventions de fitness : FitCon Ć Salt Lake City (1er-2 aoĆ»t) et FitExpo Ć Anaheim (2-3 aoĆ»t 2025).
Le produit contient 50 mg de cafĆ©ine dĆ©livrĆ©s par technologie nano sublinguale, offrant une Ć©nergie quasi instantanĆ©e via des sachets faciles Ć utiliser. En tant que sponsor Gold Ć FitCon (20 000 participants) et sponsor Ć FitExpo (33 000 participants), BUZZ BOMBā� bĆ©nĆ©ficiera dāune visibilitĆ© de premier plan, dāune large exposition marketing et dāopportunitĆ©s de distribution dāĆ©chantillons Ć tous les participants.
Lāentreprise vise Ć bouleverser le marchĆ© des supplĆ©ments prĆ©-entraĆ®nement, qui pĆØse plusieurs milliards, grĆ¢ce Ć son systĆØme innovant de dĆ©livrance offrant des effets immĆ©diats, contrairement aux supplĆ©ments traditionnels nĆ©cessitant 20 Ć 30 minutes pour agir.
Aspire Biopharma Holdings (NASDAQ:ASBP) hat die Einführung seines neuen Pre-Workout-Supplements BUZZ BOMBā� auf zwei groĆen Fitnessmessen angekündigt ā� FitCon in Salt Lake City (1.-2. August) und FitExpo in Anaheim (2.-3. August 2025).
Das Produkt enthƤlt 50 mg Koffein, das mittels sublingualer Nanotechnologie verabreicht wird und nahezu sofortige Energie durch einfach zu verwendende Portionsbeutel bietet. Als Goldsponsor bei FitCon (20.000 Teilnehmer) und Sponsor bei FitExpo (33.000 Teilnehmer) erhƤlt BUZZ BOMBā� prominente Platzierung, umfangreiche MarketingprƤsenz und Produktprobenmƶglichkeiten für alle Besucher.
Das Unternehmen mƶchte den milliardenschweren Pre-Workout-Markt mit seinem innovativen Abgabesystem revolutionieren, das sofortige Wirkung bietet, im Gegensatz zu herkƶmmlichen Pre-Workout-Supplements, die 20-30 Minuten zur Aktivierung benƶtigen.
- None.
- No sales projections or market size specifics provided
- New entrant in a highly competitive pre-workout supplement market
Sublingual nano technology delivers 50mg of caffeine rapidly to the body, bringing its unique benefits to the pre-workout market
ESTERO, FL / / July 22, 2025 / Aspire Biopharma Holdings, Inc.ā�(Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending supplement delivery technology,āÆtoday announced it plans to launch its newsublingual pre-workout supplement, BUZZ BOMBā�, at FitCon and FitExpo, two of the largest fitness conventions held annually in Salt Lake City, Utah (August 1-2) and Anaheim, CA, (August 2-3), respectively.
Featuring 50mg of caffeine and designed to support sustained energy and mental focus, BUZZ BOMBā� is bringing its unique delivery technology benefits to the multi-billion-dollar pre-workout market to help athletes and fitness enthusiasts maximize their performance potential. Buzz BOMBā�, offered in four flavors, provides nearly instant energy, in easy-to-use small sublingual packets, which can be taken right before and during work out as needed. Unlike pre-workout products that are mixed with water and taken well before a workout, BUZZ BOMBā� is sprinkled under the tongue for immediate effect.
FitCon: Mountain America ExpoCenter, Salt Lake City, UT on August 1-2, 2025, Located in Sponsor Alley
FitCon is an event that brings together fitness enthusiasts, professionals, brands, and influencers in the health and wellness industry with approximately 20,000 attendees and hundreds of exhibitors. BUZZ BOMBā� is one of seven "Gold Sponsors" at FitCon, which provides benefits including samples provided to every attendee, a large booth located along "Sponsor Alley" where all attendees pass through, as well as FitCon website marketing, advertising and communications to attendees, and a liberal exhibiting of Buzz Bomb's distinctive trademark throughout the exhibition.
To learn more about FitCon, please visit
The FitExpo: Anaheim Convention Center, Anaheim, CA, August 2-3, 2025, Booth #401
FitExpo brings together a diverse range of fitness brands, competitions, and demonstrations to inspire and guide individuals on their fitness journey and is one of the largest fitness conventions in the world with over 33,000 people expected to attend. As a convention sponsor, BUZZ BOMBā� will be provided numerous benefits and support, including:
Booth # 401 is the first one nearest the entry doors to the convention
FitExpo will publish a pre-convention media blast about BUZZ BOMBā� to over 1.8 million social media accounts including all attendees
BUZZ BOMBā� will be mentioned on all signage throughout the convention, including in the lobby where patrons enter, as well as on the convention's website, newsletter, and social media postings
BUZZ BOMBā� products will be in the gift bag given to every entrant (a sample pack of 4 different flavors)
BUZZ BOMB is planned to be personally introduced to each influencer at the show
Learn more about FitExpo at
Company representatives (mostly professional trainers) will be running "Feel the Buzz" contests at both conventions with 250 BUZZ BOMBā� t-shirts offered as prizes to contestants. The Company also plans to sell product at the conventions and generate "BUZZ".
"The launch of BUZZ BOMBā� at two of the major fitness conventions represent the ideal venues to introduce our disruptive pre-workout formula designed to boost endurance, energy metabolism, and overall performance, ensuring that athletes and fitness enthusiasts can perform at their best, both in and out of the gym," said Michael Howe, Chief Executive Officer of Aspire. "We are also very excited about the positive initial consumer feedback we received recently from our sampling of BUZZ BOMBā� to not only fitness trainers and gym owners, but to active and fitness-minded consumers, expanding the addressable market opportunity within the multi-billion-dollar health and wellness categories."
BUZZ BOMBā� Pre-workout Benefits:
ā� Speed - works nearly immediate vs. 20-30 minutes
ā� Convenience - easy to use single-use packets vs. mixing and measuring for beverages
ā� Energy management - use as needed to precisely manage caffeine intake
ā� Single Safe Active Ingredient - well-known benefits and use of caffeine
ā� Low manufacturing & packaging costs - competitive pricing with high margin potential
About the Aspire Targeted Oral Delivery Platform
Aspire's technology delivers fast-acting supplement formulations which have been developed by using our patent-pending methodology, and "trade secret" process. The technology's new mechanism of action allows for rapid sublingual absorption. The benefits of "rapid absorption" are to provide rapid impact in more precise quantities.
AboutāÆAspire Biopharma, Inc.ā�
Headquartered ināÆEstero, Fl.,āÆAspire BiopharmaāÆhas developed a disruptive technology that can deliver supplements and drugs rapidly and precisely. For more information, please visit .
Safe Harbor Statement
Certain statements made in this communication are "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of words such as "estimate," "projects," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "would," "should," "future," "propose," "potential," "target," "goal," "objective," "outlook" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the financial position, business strategy and the plans and objectives of management for future operations. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Aspire's management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the control of the parties, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Aspire Biopharma Holdings, Inc.
Contact
PCG Advisory
Kevin McGrath
+1-646-418-7002
[email protected]
SOURCE:āÆAspire Biopharma Holdings, Inc.
View the original on ACCESS Newswire